BACKGROUND: Recent studies have suggested a potential association between gastric cancer (GC) and myocardial infarction (MI), with shared pathogenic factors. This study aimed to identify these common factors and potential pharmacologic targets.
BACKGROUND: To evaluate the predictive utility of machine learning and nomogram in predicting in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS), and to visualize the model results in order to...
International journal of medical informatics
Mar 8, 2025
BACKGROUND: Machine learning (ML) models have been constructed to predict the risk of in-hospital mortality in patients with myocardial infarction (MI). Due to diverse ML models and modeling variables, along with the significant imbalance in data, th...
OBJECTIVE: We aim to develop and validate an interpretable machine-learning model that can provide critical information for the clinical treatment of critically ill patients with acute myocardial infarction (AMI).
British journal of hospital medicine (London, England : 2005)
Feb 23, 2025
The classification and treatment of myocardial infarction (MI) have evolved significantly over the past few decades, with the ST-segment elevation myocardial infarction (STEMI)/non-STEMI (NSTEMI) paradigm dominating clinical practice. While STEMI, id...
BACKGROUND: Psychosocial maladjustment threatens the recovery of patients with acute myocardial infarction (AMI), and early identification of patients with psychosocial maladjustment may facilitate provision of reference to targeted interventions. Th...
BACKGROUND: With widespread adoption of high-sensitivity troponin assays, more individuals with myocardial injury are now identified, with type 1 myocardial infarction (T1MI) being less common despite having the most well-established evidence base to...
Clinical chemistry and laboratory medicine
Feb 7, 2025
Although significant progress has been made in recent years, some important questions remain regarding the analytical performance, pathophysiological interpretation and clinical use of cardiac troponin I (cTnI) and T (cTnT) measurements. Several rece...
BACKGROUND: Safety signals for potential drug-induced adverse events (AEs) typically emerge from multiple data sources, primarily spontaneous reporting systems, despite known limitations. Increasingly, real-world data from sources such as electronic ...
Small (Weinheim an der Bergstrasse, Germany)
Feb 5, 2025
Democratizing biomarker testing at the point-of-care requires innovations that match laboratory-grade sensitivity and precision in an accessible format. Here, high-sensitivity detection of cardiac troponin I (cTnI) is demonstrated through innovations...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.